Sean Maenpaa

Sean Maenpaa

Company: Telix Pharmaceuticals

Job title: Vice-President, Global Commercialization


Choice Of Molecule & Isotope For Theranostic Indications; Exploring The Telix Pipeline 12:30 pm

Look at latest developments in theranostics for prostate cancer How theranostics hold up for renal cancer Applying this therapeutic to under served glioblastoma treatment • Integrating into existing oncology pathwayRead more

day: Day One Track B AM

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.